Latest article: |
QIAsymphony RGQ® Sets New Standards for Molecular Testing
01 Sep 2010: The QIAsymphony RGQ® from QIAGEN is a novel and flexible automated system for molecular testing, incorporating all workflow steps from sample to detection. This new and complete workflow solution is comprised of modules that can be used as stand-alone systems or combined into a fully integrated system.
QIAGEN
|
|
|
Recent articles: |
|
Exhibitors Confident in the Run-Up to BIOTECHNICA 2010
31 Aug 2010: The biotech industry is setting its sights on Hannover, where exhibitors and visitors from all over the world will convene this autumn at BIOTECHNICA 2010 from 5 to 7 October. A plethora of small, highly specialized firms will exhibit in Hannover alongside numerous companies and industry leaders, including Eppendorf, Qiagen, Sartorius and Thermo Fisher Scientific.
Deutsche Messe AG
|
New Live Cell-Impermeant Far-Red Fluorescing DNA Dye
 27 Aug 2010: The new DRAQ7™ from Biostatus Ltd. is a new live cell-impermeant far-red fluorescing DNA dye with the spectral properties that made DRAQ5™ a reagent of choice. For flow cytometry applications, DRAQ7™ rapidly labels only dead, dying and apoptotic cells in cytotoxicity and viability assays, as well as fixed cell preparations. Its far-red emission permits new combinations of dyes to be used in the understanding of apoptosis.
Biostatus Limited
|
Standardized Comet Assay System Ensures Reproducible Cancer Research Results
 26 Aug 2010: The CometAssay® Electrophoresis System and new CometAssay® Neutral Control cells from AMSBIO enable investigators to consistently optimize neutral Comet assays for highly reproducible results, and to standardize neutral electrophoresis methods between individual users and laboratories.
AMSBIO
|
ChanTest Introduces New Ion Channel and GPCR Assays for Drug Discovery and Preclinical Safety at ELRIG 2010
 25 Aug 2010: ChanTest will be featuring new ion channel and GPCR cell-based assays for screening and profiling, along with additions to the company’s leading preclinical cardiac safety services. For drug discovery, the company has recently introduced cost-effective, transiently-transfected EZCells™ reagents for ion channel profiling and CNG-mediated (cyclic nucleotide-gated) cAMP assays for GPCRs.
ChanTest Corporation
|
Hamamatsu Photonics to Introduce New Imaging Based Plate Reader at ELRIG 2010
 25 Aug 2010: Hamamatsu Photonics is to introduce its new imaging based plate reader, the FDSSµCELL, specifically developed for compound screening and assay development applications in the Pharmaceutical, CRO and Biotech Industries. The FDSSµCELL is optimised for fluorescent kinetic assays using calcium and membrane potential dyes such as FLUO4 and FMP.
Hamamatsu Photonics
|
Corning® Epic® Label-Free Cell-Based Assay: Development of a Suspension Cell Assay Using a Human Monocyte Cell Line (THP-1 Cells)
10 Aug 2010: This application note shows that the human monocyte suspension cell line THP-1 can be used in the Corning® Epic® System leading to the generation of robust results for evaluating a panel of distinct compounds.
Corning Life Sciences
|
New Range of MagSi Magnetic Beads Combine the Advantages of Small Beads with the Performance and Strength of Larger Beads
 10 Aug 2010: AMSBIO announces a new range of MagSi magnetic beads that enable faster protocols. The beads also incorporate a novel ferro fluid to combine the advantages of small beads and large surface with the magnetic performance and strength of larger beads.
AMSBIO
|
Optimizing a Corning® Epic® Biochemical Assay: An Example with the Lactate Dehydrogenase A
09 Aug 2010: This application note show that the Corning® Epic® System enables label-free direct biochemical assay for small molecule binding to an immobilized protein. Several simple steps can be performed and are necessary to optimize the assay, including selecting the right pH and buffer conditions, optimizing concentration of target bound, and evaluating assay robustness with respect to buffer conditions.
Corning Life Sciences
|
Corning® Epic® Cell-based Assays: Tolerance to DMSO Mismatching in Antagonist Assays
09 Aug 2010: This application note shows that to maximize the sensitivity of an Epic® assay, a buffer should match as closely as possible. Quantities of DMSO added greater than a mismatch of 1% result in a loss of assay sensitivity, however the IC50 values are not greatly affected.
Corning Life Sciences
|
